Program registry

An open registry of therapeutic viruses and other investigational therapies, licensed under CC BY 4.0. Each program has a stable ID (AXP000001) and lists every name it has gone by, its virus and construct where it is virus-based, its regulatory approvals, the ClinicalTrials.gov trials that name it, and what changed in them week by week.

The curated data and its rules live in the registry folder on GitHub; this week's trial changes are in What changed.

262programs
252therapeutic viruses
885names
1526linked trials
41approved programs

Trials as of the ClinicalTrials.gov snapshot of 2026-11-15. Phase and trial counts use confirmed (automatic) links only.

Explore

Oncolytic virus atlas: every oncolytic virus as a map, joined to its virus family, transgenes, the cancers its trials enrol and more. Phage therapy atlas: the same map for phage therapies, joined to the infections their trials enrol. AAV gene therapy atlas: AAV products by capsid, transgene and disease area.

By disease

Jump to: Adenoviridae · Caudoviricetes · Flaviviridae · Herelleviridae · Herpesviridae · Orthoherpesviridae · Paramyxoviridae · Parvoviridae · Picornaviridae · Poxviridae · Retroviridae · Rhabdoviridae · Spinareoviridae · Straboviridae · Togaviridae · Targeted small molecule

Adenoviridae (84)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
Ad3-hTERT-E1AAXP000072human adenovirus 3 · Ad3conditionally replicating0
Ad5-CD/TKrepAXP000049human adenovirus 5 · Ad5 (CD/TKrep)replicating0
Ad5-D24-GMCSFAXP000066human adenovirus 5 · Ad5conditionally replicating0
Ad5-RGD-D24-GMCSFAXP000068human adenovirus 5 · Ad5 (RGD fiber)conditionally replicating0
Ad5-yCD/mutTK(SR39)rep-ADPAXP000047human adenovirus 5 · Ad5 (yCD/mutTK(SR39)rep-ADP)replicatingPhase 12
Ad5-yCD/mutTKSR39rep-hIL12AXP000048human adenovirus 5 · Ad5 (yCD/mutTKSR39rep-hIL12)replicatingPhase 12
Ad5/3-Cox2L-D24AXP000069human adenovirus 5 · Ad5/3 chimeraconditionally replicating0
Ad5/3-D24-hNISAXP000071human adenovirus 5 · Ad5/3 chimeraconditionally replicating0
Ad5/3-E2F-d24-GMCSFAXP000067human adenovirus 5 · Ad5/3 chimeraconditionally replicating0
Ad5/3-hTERT-E1A-hCD40LAXP000070Ad5/3-hTERT-CD40Lhuman adenovirus 5 · Ad5/3 chimeraconditionally replicating0
AdAPT-001AXP000040human adenovirus 5 · Ad5 (AdAPT-001)conditionally replicatingPhase 21
Adze1.CAXP000063human adenovirus (serotype not reported)conditionally replicatingPhase 11
BioTTT001AXP000046Ad-TD-nsIL12, Ad5-TD-nsIL-12human adenovirus 5 · Ad5 (Ad-TD)conditionally replicatingPhase 210
CAdVECAXP000042human adenovirus 5 · binary oncolytic adenovirus (CAdVEC)conditionally replicatingPhase 11
CG7060AXP000054CV706human adenovirus 5 · Ad5 (CG7060)conditionally replicating0
CG7870AXP000053CV787human adenovirus 5 · Ad5 (CG7870)conditionally replicatingPhase 1/22
CRAd-S-pk7AXP000052NSC-CRAd-S-pk7, NSC-CRAd-Survivin-pk7human adenovirus 5 · Ad5 (CRAd-S-pk7)conditionally replicatingPhase 13
cretostimogene grenadenorepvecAXP000006cretostimogene, CG0070human adenovirus 5 · Ad5 (CG0070)conditionally replicatingPhase 312
delolimogene mupadenorepvecAXP000007LOAd703, Oncolytic Adenovirus LOAd703human adenovirus 5 · Ad5/35 chimeraconditionally replicatingPhase 1/24
enadenotucirevAXP000012EnAd, ColoAd1human adenovirus 11 · Ad11p/Ad3 group B chimera (ColoAd1)conditionally replicatingPhase 1/25
GM103AXP000043human adenovirus 5conditionally replicatingPhase 1/21
H101AXP000003Oncorine, Oncolytic Adenovirus H101, rAd5 H101human adenovirus 5 · Ad5 (H101)conditionally replicatingPhase 4yes (NMPA)21
H103AXP000064human adenovirus 2 · Ad2 (H103)conditionally replicating0
ICOVIR-5AXP000050human adenovirus 5 · Ad5 (ICOVIR-5)conditionally replicatingPhase 1/22
ICOVIR-7AXP000051human adenovirus 5 · Ad5 (ICOVIR-7)conditionally replicating0
ICVB-1042AXP000055human adenovirus 5 · Ad5 (ICVB-1042)conditionally replicatingPhase 11
igrelimogene litadenorepvecAXP000009Ad5/3-E2F-d24-hTNFa-IRES-hIL2, TILT-123human adenovirus 5 · Ad5/3 chimeraconditionally replicatingPhase 1/26
Ixovex-1AXP000057human adenovirus 5 · Ad5 (Ixovex-1)conditionally replicatingPhase 1/21
KD01AXP000058human adenovirus (serotype not reported)conditionally replicatingPhase 12
KH901AXP000065human adenovirus 5 · Ad5 (KH901)conditionally replicating0
lontucirevAXP000033CI-1042, ONYX-015, E1B 55kDa mutant adenovirus dl1520human adenovirus 5 · Ad2/Ad5 chimera (dl1520)conditionally replicatingPhase 11
MEM-288AXP000041human adenovirus 5 · Ad5 (MEM-288)conditionally replicatingPhase 11
NG-350AAXP000038human adenovirus 11 · Ad11p/Ad3 group B chimera (T-SIGn)conditionally replicatingPhase 14
NG-641AXP000039human adenovirus 11 · Ad11p/Ad3 group B chimera (T-SIGn)conditionally replicatingPhase 13
NRG-103AXP000060human adenovirus (serotype not reported)conditionally replicatingPhase 12
ONCOS-102AXP000035Ad5/3-D24-GMCSF, CGTG-102human adenovirus 5 · Ad5/3 chimeraconditionally replicatingPhase 27
ORCA-010AXP000037human adenovirus 5 · Ad5 Delta-24-RGD (T1)conditionally replicatingPhase 1/21
suratadenoturevAXP000034Telomelysin, OBP-301, Telomelycinhuman adenovirus 5 · Ad5 (OBP-301)conditionally replicatingPhase 28
SynOV1.1AXP000045human adenovirus 5 · Ad5 (SynOV1.1)conditionally replicatingPhase 11
tasadenoturevAXP000005Ad5-Delta24RGD, DNX-2401, Ad5-d24-RGDhuman adenovirus 5 · Ad5 Delta-24-RGDconditionally replicatingPhase 210
tezemlimogene daxadenorepvecAXP000036DNX-2440human adenovirus 5 · Ad5 Delta-24-RGDconditionally replicatingPhase 12
THEO-260AXP000056human adenovirus (serotype not reported)Phase 1/22
TS-2021AXP000059human adenovirus (serotype not reported)conditionally replicatingPhase 11
VT-101AXP000061human adenovirus (serotype not reported)conditionally replicatingPhase 12
YH-02AXP000062human adenovirus (serotype not reported)conditionally replicatingPhase 21
YSCH-01AXP000044Recombinant L-IFN adenovirus injectionhuman adenovirus 5 · Ad5 (ZD55/CTGVT)conditionally replicatingPhase 1/25
zabilugene almadenorepvecAXP000008VCN-01human adenovirus 5 · Ad5 (VCN-01)conditionally replicatingPhase 27

In vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
Ad-RTS-hIL-12AXP000146INXN-2001human adenovirus 5 · Ad5non replicatingPhase 28
aglatimagene besadenovecAXP000144GliAtak, ProstAtak, Virafirhuman adenovirus 5 · Ad5non replicatingPhase 313
alferminogene tadenovecAXP000151Generx, Ad5FGF-4human adenovirus 5 · Ad5non replicatingPhase 34
ASN-002AXP000149TG1042human adenovirusnon replicatingPhase 210
contusugene ladenovecAXP000142Advexin, INGN 201, RPR/INGN-201human adenovirus 5 · Ad5non replicatingPhase 39
E10AAXP000148Ad-rhENDOhuman adenovirus 5 · Ad5non replicatingPhase 32
GendicineAXP000141Genkaxinhuman adenovirus 5 · Ad5non replicatingPhase 4yes (NMPA)4
golnerminogene pradenovecAXP000150TNFerade, ADgv EGR.TNF.11Dhuman adenovirus 5 · Ad5non replicatingPhase 37
INGN 241AXP000153human adenovirus 5 · Ad5non replicatingPhase 21
nadofaragene firadenovecAXP000143Adstiladrin, nadofaragene firadenovec-vncg, rAd-IFN/Syn3human adenovirus 5 · Ad5non replicatingPhase 4yes (FDA)16
ofranergene obadenovecAXP000145Ofra-Vec, VB-111human adenovirus 5 · Ad5non replicatingPhase 37
SCH-58500AXP000152ACN53human adenovirus 5 · Ad5non replicatingPhase 2/33
sitimagene ceradenovecAXP000147Cereprohuman adenovirus 5 · Ad5non replicating0

Ex vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
AdVTMM2-transduced dendritic cell vaccineAXP000166AdVTMM2human adenovirus 5 · Ad5non replicating0

Vaccine vector

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
Ad-MAGEA3AXP000165AdMA3human adenovirus 5 · Ad5non replicatingPhase 1/23
Ad26.COV2.SAXP000168Jcovden, Ad26COVS1, JNJ-78436735human adenovirus 26 · Ad26non replicatingPhase 4yes (FDA, EMA)33
Ad26.Mos4.HIVAXP000174human adenovirus 26 · Ad26non replicatingPhase 38
Ad26.RSV.preFAXP000175human adenovirus 26 · Ad26non replicatingPhase 315
Ad26.ZEBOVAXP000172Zabdeno, Ad26.ZEBOV-GPhuman adenovirus 26 · Ad26non replicatingPhase 3yes (EMA)25
Ad5-EBOVAXP000173human adenovirus 5 · Ad5non replicatingPhase 1yes (NMPA)3
Ad5-hGCC-PADREAXP000164human adenovirus 5 · Ad5non replicatingPhase 11
Ad5-nCoVAXP000169Convidecia, Convidecia Airhuman adenovirus 5 · Ad5non replicatingPhase 4yes (NMPA, other)18
BBV154AXP000176iNCOVACCchimpanzee adenovirusnon replicatingPhase 3yes (other)4
ChAdOx1 nCoV-19AXP000167Covishield, Vaxzevria, AZD1222chimpanzee adenovirus Y25 · ChAdOx1non replicatingPhase 4yes (MHRA, EMA)59
ETBX-011AXP000154human adenovirus 5 · Ad5 [E1-, E2b-]non replicatingPhase 220
ETBX-021AXP000155human adenovirus 5 · Ad5 [E1-, E2b-]non replicatingPhase 210
ETBX-051AXP000156human adenovirus 5 · Ad5 [E1-, E2b-]non replicatingPhase 220
ETBX-061AXP000157human adenovirus 5 · Ad5 [E1-, E2b-]non replicatingPhase 221
ETBX-071AXP000158human adenovirus 5 · Ad5 [E1-, E2b-]non replicatingPhase 23
Gam-COVID-VacAXP000170Sputnik V, Gam-COVID-Vac-Lyo, Gam-COVID-Vac-Mhuman adenovirus 26 · rAd26 (dose 1); rAd5 (dose 2)non replicatingPhase 3yes (other)20
GRAd-COV2AXP000177gorilla adenovirusnon replicatingPhase 2/32
GRT-C903AXP000162chimpanzee adenovirus C68 · ChAdV68non replicatingPhase 1/22
lutadenovec autogeneAXP000161GRT-C901chimpanzee adenovirus C68 · ChAdV68non replicatingPhase 2/33
NOUS-209AXP000163GAd-209-FSP, GAd20-209-FSP, MVA-209-FSPgreat ape adenovirus 20 · GAd20non replicatingPhase 1/22
PRGN-2009AXP000160gorilla adenovirusnon replicatingPhase 24
Sputnik LightAXP000171human adenovirus 26 · rAd26non replicatingPhase 3yes (other)2
zopapogene imadenovecAXP000159Papzimeos, zopapogene imadenovec-drba, PRGN-2012gorilla adenovirusnon replicatingPhase 4yes (FDA)4

Caudoviricetes (30)

Phage

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
AB-PA01AXP000223Pseudomonas aeruginosa bacteriophage (cocktail)replicating1
AchromoPhageAXP000240Achromobacter bacteriophage (cocktail)replicatingPhase 11
AP-PA02AXP000220Pseudomonas aeruginosa bacteriophage (cocktail)replicatingPhase 22
AP-SA02AXP000221Staphylococcus aureus bacteriophage (cocktail)replicatingPhase 1/21
BACTELIDEAXP000238PL-03-BMbacteriophage cocktail against S. aureus, P. aeruginosa and K. pneumoniaereplicatingPhase 1/21
BFC-1AXP000247cocktail of P. aeruginosa phages 14/1 and PNM and S. aureus phage ISPreplicating0
BX004AXP000217BX004-APseudomonas aeruginosa bacteriophage (cocktail)replicatingPhase 22
BX005AXP000219BX005-AStaphylococcus aureus bacteriophage (cocktail)replicatingPhase 1/21
BX211AXP000218Staphylococcus aureus bacteriophage (patient-matched from a phage bank)replicating0
DP-QB-MYA-002AXP000241Mycobacterium abscessus bacteriophage (cocktail)replicatingPhase 11
DP-QB-PSA-005AXP000242Pseudomonas aeruginosa bacteriophage (five-phage cocktail)replicatingPhase 2/31
DP-QB-STA-005AXP000243Staphylococcus aureus bacteriophage (five-phage cocktail)replicatingPhase 2/31
DUOFAGAXP000234bacteriophage cocktail against S. aureus and P. aeruginosareplicatingPhase 1/21
EcoActiveAXP000225Escherichia coli bacteriophage (cocktail)replicatingPhase 1/21
LBP-EC01AXP000215Escherichia coli bacteriophage (six-phage cocktail)replicatingPhase 22
MP101AXP000236Pseudomonas aeruginosa bacteriophagereplicatingPhase 37
MuddyAXP000246Muddy_HRMN0052Mycobacterium bacteriophage MuddyreplicatingPhase 11
NTR-101AXP000237bacteriophage preparation against cytolysin-positive Enterococcus faecalisreplicatingPhase 11
PGX-0100AXP000239phage cocktail-SPKbacteriophage cocktail of 14 phages against S. aureus, P. aeruginosa and K. pneumoniaereplicatingPhase 11
PP1131AXP000228Pseudomonas aeruginosa bacteriophage (12-phage cocktail)replicating0
PP1493AXP000229Staphylococcus aureus bacteriophagereplicatingPhase 21
PP1815AXP000230Staphylococcus aureus bacteriophagereplicatingPhase 21
PyophageAXP000244Pyo bacteriophagepolyvalent bacteriophage cocktail (Pyo) against staphylococci, streptococci and enterococci, E. coli, Proteus mirabilis and P. aeruginosareplicating0
ShigActiveAXP000226Shigella bacteriophage (cocktail)replicatingPhase 1/21
SNIPR001AXP000216Escherichia coli bacteriophage (four-phage cocktail)replicatingPhase 1/22
TP-102AXP000224bacteriophage cocktail against P. aeruginosa, S. aureus and A. baumanniireplicatingPhase 22
TP-122AAXP000232TP-122Pseudomonas aeruginosa bacteriophagereplicatingPhase 1/21
VRELysinAXP000227Enterococcus bacteriophage (cocktail)replicatingPhase 1/21
WPP-201AXP000233bacteriophage cocktail of eight phages lytic for P. aeruginosa, S. aureus and E. colireplicatingPhase 11
WRAIR-PAM-CF1AXP000235Pseudomonas aeruginosa bacteriophage (cocktail)replicatingPhase 1/21

Flaviviridae (3)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
West Nile virus Egypt 101AXP000131West Nile virus · Egypt 101replicating0

Vaccine vector

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
CYD-TDVAXP000206Dengvaxiayellow fever virus · 17D-204 backbone (CYD-1 to CYD-4 chimeras)replicatingPhase 3yes (EMA, FDA)10
ImojevAXP000207Imojev MD, JE-CV, ChimeriVax-JEyellow fever virus · 17D-204 backbone (JE-CV chimera)replicatingPhase 4yes (other, TGA)19

Herelleviridae (2)

Phage

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
AB-SA01AXP000222Staphylococcus phage K-related bacteriophage (three-phage cocktail)replicatingPhase 12
StafalAXP000231Staphylococcus aureus bacteriophage (Kayvirus)replicating0

Herpesviridae (8)

In vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
beremagene geperpavecAXP000193Vyjuvek, B-VEC, KB103herpes simplex virus 1non replicatingPhase 3yes (FDA, EMA, PMDA)4
KB105AXP000198herpes simplex virus 1non replicatingPhase 22
KB301AXP000199herpes simplex virus 1non replicatingPhase 11
KB407AXP000194herpes simplex virus 1non replicatingPhase 12
KB408AXP000195herpes simplex virus 1non replicatingPhase 11
KB707AXP000196herpes simplex virus 1non replicatingPhase 1/22
KB801AXP000197herpes simplex virus 1non replicatingPhase 1/21
NP2AXP000200NP2 enkephalinherpes simplex virus 1non replicatingPhase 23

Orthoherpesviridae (25)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
BS-006AXP000090herpes simplex virus 2 · HG52conditionally replicatingPhase 1/23
C134AXP000085herpes simplex virus 1 · Fconditionally replicatingPhase 13
CAN-3110AXP000087rQNestin34.5v.2herpes simplex virus 1 · Fconditionally replicatingPhase 11
canerpaturevAXP000076HF10, TBI-1401, C-REVherpes simplex virus 1 · HF10 (derived from HSV-1 strain HF)replicatingPhase 29
G207AXP000074HSV G207herpes simplex virus 1 · Fconditionally replicatingPhase 26
HSV1716AXP000073Seprehvir, RL1 mutant HSV-1 1716herpes simplex virus 1 · 17+conditionally replicatingPhase 1/23
JNJ-87704916AXP000092herpes simplex virus 1conditionally replicatingPhase 11
M032AXP000086M032-HSV-1herpes simplex virus 1 · Fconditionally replicatingPhase 1/23
MVR-C5252AXP000081herpes simplex virus 1conditionally replicatingPhase 12
NV1020AXP000075R7020herpes simplex virus 1 · R7020 (HSV-1 F background with HSV-2 sequences)conditionally replicatingPhase 1/22
OH2AXP000089OH2 injection, oHSV2hGM-CSFherpes simplex virus 2 · HG52conditionally replicatingPhase 414
ON-01AXP000138herpes simplex virus 1conditionally replicatingPhase 1/21
ONCR-177AXP000084herpes simplex virus 1conditionally replicatingPhase 11
OrienX010AXP000077herpes simplex virus 1 · clinical isolate (Chinese Han patient)conditionally replicatingPhase 25
R130AXP000091herpes simplex virus 1conditionally replicatingEarly phase 18
RP3AXP000079herpes simplex virus 1 · RH018Aconditionally replicatingPhase 23
rRp450AXP000088herpes simplex virus 1 · KOSconditionally replicatingPhase 11
STI-1386AXP000135Seprehvec, Oncolytic HSV-1 STI-1386herpes simplex virus 1conditionally replicatingPhase 11
sturlimogene erparepvecAXP000078herpes simplex virus 1 · RH018Aconditionally replicatingPhase 2/36
T3011AXP000080MVR-T3011herpes simplex virus 1conditionally replicatingPhase 212
talimogene laherparepvecAXP000001Imlygic, JS1 34.5-hGMCSF 47- pA-, T-VECherpes simplex virus 1 · JS1conditionally replicatingPhase 3yes (FDA, EMA)55
teserpaturevAXP000002Delytact, DS-1647, G47∆herpes simplex virus 1 · Fconditionally replicatingyes (PMDA)0
VG161AXP000082Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)herpes simplex virus 1conditionally replicatingPhase 29
VG2025AXP000083herpes simplex virus 1conditionally replicatingPhase 26
vusolimogene oderparepvecAXP000010Tudriqev, vusolimogene oderparepvec-wtpgherpes simplex virus 1 · RH018Aconditionally replicatingPhase 3yes (FDA)8

Paramyxoviridae (11)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
MEDI5395AXP000118recNDV(GM-CSF)Newcastle disease virus · LaSota-derived recombinantreplicatingPhase 11
MTH-68/HAXP000116Newcastle disease virus · MTH-68/Hreplicating0
mumps virus (Asada series)AXP000140mumps virusreplicating0
MV-CEAAXP000112Carcinoembryonic Antigen-Expressing Measles Virusmeasles morbillivirus · Edmonston-NSe vaccine lineagereplicatingPhase 12
MV-NISAXP000113Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symportermeasles morbillivirus · Edmonston-NSe vaccine lineagereplicatingPhase 211
MV-s-NAPAXP000114MV Encoding NAPmeasles morbillivirus · Edmonston-NSe vaccine lineagereplicatingPhase 11
NDV-HUJAXP000117Newcastle disease virus · HUJ (lentogenic)replicating0
PV701AXP000115Oncolytic Newcastle Disease Virus Strain PV701Newcastle disease virus · PV701 (attenuated MK107 lineage)replicatingPhase 12

Vaccine vector

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
MV-CHIKAXP000208V184measles morbillivirus · Schwarz vaccine strainreplicatingPhase 24
NDV-HXP-SAXP000209PatriaNewcastle disease virus · LaSotareplicatingPhase 2/3yes (other)6

Other

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
HVJ-EAXP000130GEN0101Sendai virus · HVJ (Z strain lineage), UV-inactivated envelopenon replicatingPhase 22

Parvoviridae (16)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
ParvOryxAXP000127H-1 parvovirus · H-1PV (wild-type)replicatingPhase 1/22

In vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
4D-150AXP000259adeno-associated virus (R100 capsid variant) · R100non replicatingPhase 35
alipogene tiparvovecAXP000248Glybera, AMT-011adeno-associated virus 1 · AAV1non replicatingPhase 2/3withdrawn5
botaretigene sparoparvovecAXP000260bota-vec, AAV-RPGR, MGT009adeno-associated virus 5 · AAV5non replicatingPhase 33
dalnacogene ponparvovecAXP000256XinJiuning, BBM-H901adeno-associated virusnon replicatingPhase 1yes (NMPA, other)1
delandistrogene moxeparvovecAXP000254Elevidys, SRP-9001adeno-associated virus rh74 · AAVrh74non replicatingPhase 4yes (FDA, PMDA)11
eladocagene exuparvovecAXP000251Kebilidi, Upstaza, PTC-AADCadeno-associated virus 2 · AAV2non replicatingPhase 2yes (EMA, FDA)6
etranacogene dezaparvovecAXP000253Hemgenix, AMT-061adeno-associated virus 5 · AAV5non replicatingPhase 3yes (FDA, EMA)6
fidanacogene elaparvovecAXP000255Beqvez, Durveqtix, PF-06838435adeno-associated virus rh74 (variant capsid) · AAVRh74varnon replicatingPhase 3yes (FDA)4
ixoberogene soroparvovecAXP000258ixo-vec, ADVM-022adeno-associated virus (7m8 capsid variant) · AAV.7m8non replicatingPhase 38
laruparetigene zovaparvovecAXP000261AGTC-501, laru-zovaadeno-associated virusnon replicatingPhase 2/33
OCU400AXP000262AAV-hNR2E3adeno-associated virus 5 · AAV5non replicatingPhase 33
onasemnogene abeparvovecAXP000250Itvisma, Zolgensma, OAV-101adeno-associated virus 9 · AAV9non replicatingPhase 4yes (FDA, PMDA, EMA)22
surabgene lomparvovecAXP000257ABBV-RGX-314, sura-vec, RGX-314adeno-associated virus 8 · AAV8non replicatingPhase 310
valoctocogene roxaparvovecAXP000252Roctavian, BMN 270adeno-associated virus 5 · AAV5non replicatingPhase 3yes (EMA, FDA)7
voretigene neparvovecAXP000249Luxturna, AAV2-hRPE65v2adeno-associated virus 2 · AAV2non replicatingPhase 3yes (FDA, EMA, PMDA)6

Picornaviridae (4)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
gebasaxturevAXP000123CAVATAK, V937coxsackievirus A21 · KuykendallreplicatingPhase 214
lerapolturevAXP000124PVSRIPOpoliovirus 1 · Sabin type 1 with HRV2 IRESreplicatingPhase 212
RigvirAXP000125echovirus E7 · ECHO-7 (Rigvir isolate)replicatingyes (other)0
SVV-001AXP000122NTX-010, Seneca Valley Virus-001Senecavirus A · SVV-001 (wild-type isolate)replicatingPhase 24

Poxviridae (41)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
ASP9801AXP000102vaccinia virusconditionally replicatingPhase 11
BT-001AXP000095TG6030vaccinia virus · Copenhagenconditionally replicatingPhase 36
CF33-CD19AXP000101onCARlytics, CF33-CD19tchimeric orthopoxvirus (CF33) · CF33conditionally replicatingPhase 11
CF33-hNISAXP000099VAXINIA, HOV2chimeric orthopoxvirus (CF33) · CF33conditionally replicatingPhase 12
CF33-hNIS-antiPDL1AXP000100CHECKvaccchimeric orthopoxvirus (CF33) · CF33conditionally replicatingPhase 11
GC001AXP000108vaccinia virusconditionally replicatingPhase 23
GO306AXP000109vaccinia virusconditionally replicatingPhase 11
hV01AXP000103Recombinant human IL-21-expressing oncolytic vaccinia virus injectionvaccinia virusconditionally replicatingPhase 23
IDOV-ImmuneAXP000110vaccinia virusconditionally replicatingPhase 12
IDOV-SAFEAXP000137vaccinia virusconditionally replicatingPhase 1/23
JX-929AXP000097vvDD-CDSRvaccinia virus · Western Reserveconditionally replicatingPhase 11
olvimulogene nanivacirepvecAXP000093Olvi-Vec, GLV-1h68, GL-ONC1vaccinia virus · Lister (LIVP)conditionally replicatingPhase 310
OTS-412AXP000107vaccinia virusconditionally replicatingPhase 13
pexastimogene devacirepvecAXP000011JX-594, TG-6006, Pexa-Vecvaccinia virus · Wyethconditionally replicatingPhase 320
PF-07263689AXP000105vaccinia virusconditionally replicatingPhase 11
RGV005AXP000139CD19-CAR novel oncolytic vaccinia virusvaccinia virusconditionally replicatingPhase 11
TBio-6517AXP000104RIVAL-01vaccinia virus · Copenhagenconditionally replicatingPhase 11
TG6002AXP000094T601, TG6002/5-FCvaccinia virus · Copenhagenconditionally replicatingPhase 1/24
TG6050AXP000096vaccinia virus · Copenhagenconditionally replicatingPhase 11
VET3-TGIAXP000106vaccinia virusconditionally replicatingPhase 11
VV-GMCSF-LactAXP000111Double Recombinant Vaccinia Virus VV-GMCSF-Lactvaccinia virus · LIVPconditionally replicatingPhase 11
vvDD-hIL2-RG-1AXP000098vvDD-hIL2-2-RG-1vaccinia virus · Western Reserveconditionally replicatingPhase 11

In vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
MQ710AXP000192MVAdeltaE5R-Flt3L-OX40Lvaccinia virus · MVA (E5R-deleted)non replicatingPhase 11

Vaccine vector

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
ALVAC(2)-NY-ESO-1(M)/TRICOMAXP000189vCP2292canarypox virus · ALVAC(2)non replicatingPhase 1/23
ALVAC-CEA-B7.1AXP000188canarypox virus · ALVACnon replicatingPhase 21
ALVAC-HIV (vCP1521)AXP000202vCP1521canarypox virus · ALVAC (vCP1521)non replicatingPhase 34
ALVAC-HIV (vCP2438)AXP000203vCP2438canarypox virus · ALVAC (vCP2438)non replicatingPhase 2/34
CV301AXP000180CV301-V/F, CVAC-301, FPV-CV301vaccinia virus · MVA-BN prime; fowlpox (FPV-CV301) boostnon replicatingPhase 27
mesmulogene ancovacivecAXP000181TG4010, MVA-MUC1-IL2vaccinia virus · MVAnon replicatingPhase 2/35
MVA E2AXP000191MVA E2 therapeutic vaccinevaccinia virus · MVAnon replicating0
MVA-5T4AXP000184TroVax, OXB-301vaccinia virus · MVAnon replicatingPhase 311
MVA-BN-Brachyury-TRICOMAXP000185BN-Brachyury, FPV-Brachyury-TRICOM, MVA-BN-Brachyuryvaccinia virus · MVA-BN prime; fowlpox (FPV-Brachyury) boostnon replicatingPhase 26
MVA-BN-FiloAXP000201Mvabeavaccinia virus · MVA-BNnon replicatingPhase 3withdrawn22
MVA-BN-HER2AXP000186BN-HER2vaccinia virus · MVA-BNnon replicatingPhase 12
MVA-BN-RSVAXP000204vaccinia virus · MVA-BNnon replicatingPhase 35
p53MVAAXP000187MVA-p53vaccinia virus · MVAnon replicatingPhase 24
PANVACAXP000179falimarev, inalimarev, PANVAC-Fvaccinia virus · PANVAC-V (vaccinia) prime; PANVAC-F (fowlpox) boostreplicatingPhase 36
rilimogene galvacirepvec/rilimogene glafolivecAXP000178rilimogene galvacirepvec, rilimogene glafolivec, PROSTVACvaccinia virus · PROSTVAC-V (vaccinia) prime; PROSTVAC-F (fowlpox) boostreplicatingPhase 321
TA-HPVAXP000190Human Papillomavirus Tumor Antigen Vaccinevaccinia virusreplicatingPhase 24
TG4050AXP000183vaccinia virus · MVAnon replicatingPhase 1/22
tipapkinogene sovacivecAXP000182TG4001, MVA-HPV-IL2, MVA-HPV16E6/E7-IL2vaccinia virus · MVAnon replicatingPhase 22

Retroviridae (14)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
vocimagene amiretrorepvecAXP000126Toca 511murine leukemia virus · amphotropic MLV-based replicating vectorreplicatingPhase 2/310

In vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
Rexin-GAXP000210Mx-dnG1, DeltaRex-G, Retrovector Encoding Mutant Anti-Cyclin G1murine leukemia virus · MoMLV-based pathotropic vectornon replicatingPhase 2yes (other)6

Ex vivo gene transfer

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
anitocabtagene autoleucelAXP000022anito-cel, CART-ddBCMAlentivirusnon replicatingPhase 38
axicabtagene ciloleucelAXP000014Yescarta, KTE-C19, axi-celretrovirusnon replicatingPhase 4yes (FDA, EMA, PMDA)58
brexucabtagene autoleucelAXP000015Tecartus, KTE-X19, brexu-celretrovirusnon replicatingPhase 2yes (FDA, EMA)21
ciltacabtagene autoleucelAXP000018Carvykti, JNJ-4528, JNJ-68284528lentivirusnon replicatingPhase 4yes (FDA, EMA, PMDA)22
equecabtagene autoleucelAXP000021Fucaso, CT103A, IBI326lentivirusnon replicatingPhase 3yes (NMPA)12
idecabtagene vicleucelAXP000017Abecma, bb2121, ide-cellentivirusnon replicatingPhase 3yes (FDA, EMA, PMDA)19
lisocabtagene maraleucelAXP000016Breyanzi, JCAR017, liso-cellentivirusnon replicatingPhase 3yes (FDA, PMDA, EMA)36
obecabtagene autoleucelAXP000019Aucatzyl, AUTO1, obe-cellentivirusnon replicatingPhase 2yes (FDA, EMA)8
relmacabtagene autoleucelAXP000020Carteyva, JWCAR029, relma-cellentivirusnon replicatingPhase 4yes (NMPA)20
StrimvelisAXP000211GSK2696273murine leukemia virus · MoMLV-derived gamma-retroviral vector (GSK3336223)non replicatingPhase 4yes (EMA)5
tisagenlecleucelAXP000013Kymriah, CTL019, tisa-cellentivirusnon replicatingPhase 3yes (FDA, EMA, PMDA)55
ZalmoxisAXP000212murine leukemia virus · SFCMM-3 Mut2 #48non replicatingyes (EMA)0

Rhabdoviridae (8)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
BI 1831169AXP000120vesicular stomatitis Indiana virus · VSV-GP chimerareplicatingPhase 12
MG1-MAGEA3AXP000121MG1MA3, MG1 Maraba/MAGE-A3Maraba virus · MG1 (G Q242R, M L123W)replicatingPhase 1/23
OVV-01AXP000132oncolytic virus (OVV-01) injectionvesicular stomatitis Indiana virus · Indiana, recombinantreplicatingPhase 25
RevottackAXP000134vesicular stomatitis Indiana virusreplicatingPhase 11
VSV-02AXP000133VSV-02 Injectionvesicular stomatitis Indiana virus · attenuatedreplicatingPhase 11
VSV-hIFNbetaAXP000136Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta, VSV-hIFN-bvesicular stomatitis Indiana virus · Indiana, recombinantreplicatingPhase 26
VSV-IFNbeta-NISAXP000119Voyager-V1, VSV-hIFNbeta-NIS, VSV-IFNb-NISvesicular stomatitis Indiana virus · Indiana, recombinantreplicatingPhase 27

Vaccine vector

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
rVSVΔG-ZEBOV-GPAXP000205Ervebo, rVSV-ZEBOVvesicular stomatitis Indiana virus · Indiana, rVSVΔGreplicatingPhase 4yes (EMA, FDA)14

Spinareoviridae (1)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
pelareorepAXP000004Reolysin, PO-BB0209mammalian orthoreovirus · type 3 DearingreplicatingPhase 335

Straboviridae (1)

Phage

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
T4 coliphage cocktail (Nestlé)AXP000245T4 phage cocktailEscherichia coli T4-like bacteriophage (cocktail)replicating1

Togaviridae (4)

Oncolytic

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
M1-c6v1AXP000129Getah virus · M1-c6v1replicatingPhase 12
VRT106AXP000128Getah virus · oncolytic virus M1 (VRT106)replicatingPhase 2/39

Vaccine vector

ProgramIDAlso known asVirus · strainReplicationHighest phaseApprovedTrials
AVX701AXP000213CEA(6D) VRPVenezuelan equine encephalitis virus · VEE replicon, packaged as virus-like replicon particlesnon replicatingPhase 1/22
AVX901AXP000214HER2 ECDTM VRP, VRP-HER2Venezuelan equine encephalitis virus · VEE replicon, packaged as virus-like replicon particlesnon replicatingPhase 22

Targeted small molecule (10)

ProgramIDAlso known asPlatform · targetsHighest phaseApprovedTrials
adagrasibAXP000024Krazati, MRTX849small molecule · KRASPhase 339
daraxonrasibAXP000027Rasonque, RMC-6236small molecule · KRAS; NRAS; HRASPhase 322
divarasibAXP000025GDC-6036, RG6330small molecule · KRASPhase 315
elironrasibAXP000028RMC-6291small molecule · KRASPhase 1/24
fulzerasibAXP000031Dupert, GFH925, IBI351small molecule · KRASPhase 314
glecirasibAXP000030艾瑞凯, JAB-21822small molecule · KRASPhase 317
MRTX1133AXP000026small molecule · KRASPhase 11
olomorasibAXP000032LY3537982small molecule · KRASPhase 318
sotorasibAXP000023Lumakras, Lumykras, AMG 510small molecule · KRASPhase 471
zoldonrasibAXP000029RM-036, RMC-9805small molecule · KRASPhase 38